NH TherAguix NEWS

€13M A series funding

NH TherAguix, a start-up specializing in nanomedicine for cancer radiotherapy, announces a €13 million round of fundraising, led by Bpifrance – Grenoble/Lyon/Paris (France) – 11 April 2019

View Press Release

Archives

2024
2023
2022
2021
2019

Get our newsletter

We inform you that your email address will be used only for the monthly sending of a newsletter. Each mailing will contain an unsubscribe link. To learn more about the management of your data and your rights, please consult the page https://nhtheraguix.com/privacy-policy.

NH TherAguix SA – 19 chemin des Prés – 38240 Meylan – FRANCE
Phone : +33 (0)4 76 24 20 23

Legals
Privacy Policy
Sitemap
Contact
Cookies Policy

Manage Cookie Consent

We use cookies to optimize our website and our service.

Fonctionneal Fonctionneal Always active

The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistiques Statistiques

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Preferences

{title} {title} {title}

NH TherAguix NEWS

€13M A series funding

Categories

Archives